Cargando…

Herbal medicine (Hepad) prevents dopaminergic neuronal death in the rat MPTP model of Parkinson’s disease

BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra. The purpose of this study was to examine neuroprotective effects of Hepad S1, an herbal medicine used for the treatment of PD, in in vitro and in vivo models of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Dong Hee, Choi, Jeong June, Park, Byung-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712963/ https://www.ncbi.nlm.nih.gov/pubmed/31467840 http://dx.doi.org/10.1016/j.imr.2019.07.005

Ejemplares similares

Mitigation Effects of a Novel Herbal Medicine, Hepad, on Neuroinflammation, Neuroapoptosis, and Neuro-Oxidation
por: Song, Da Hye, et al.
Publicado: (2018)

Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons
por: Hong, J, et al.
Publicado: (2015)

Quercetin Protects against MPP(+)/MPTP-Induced Dopaminergic Neuron Death in Parkinson's Disease by Inhibiting Ferroptosis
por: Lin, Zhi-Hao, et al.
Publicado: (2022)

Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson’s Disease via Autophagy and Mitochondrial ROS Clearance
por: Lu, Ming, et al.
Publicado: (2016)

PEP-1-HO-1 prevents MPTP-induced degeneration of dopaminergic neurons in a Parkinson’s disease mouse model
por: Youn, Jong Kyu, et al.
Publicado: (2014)

Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models
por: He, Xuan, et al.
Publicado: (2019)

MicroRNA-212-5p Prevents Dopaminergic Neuron Death by Inhibiting SIRT2 in MPTP-Induced Mouse Model of Parkinson’s Disease
por: Sun, Sifan, et al.
Publicado: (2018)

Neuroprotective Effects of Tetramethylpyrazine against Dopaminergic Neuron Injury in a Rat Model of Parkinson's Disease Induced by MPTP
por: Lu, Chen, et al.
Publicado: (2014)

Tat-Fused Recombinant Human SAG Prevents Dopaminergic Neurodegeneration in a MPTP-Induced Parkinson’s Disease Model
por: Sohn, Eun Jeong, et al.
Publicado: (2014)

Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons
por: Goloborshcheva, Valeria V., et al.
Publicado: (2022)

Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson's Disease
por: Wi, Rayul, et al.
Publicado: (2020)

Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease
por: Vijitruth, Rattanavijit, et al.
Publicado: (2006)

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease
por: Chung, Young Cheul, et al.
Publicado: (2013)

Cerebroventricular Microinjections of MPTP on Adult Zebrafish Induces Dopaminergic Neuronal Death, Mitochondrial Fragmentation, and Sensorimotor Impairments
por: Kalyn, Michael, et al.
Publicado: (2021)

DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson’s disease
por: Kinugawa, Kiyoka, et al.
Publicado: (2013)

Cdk5 Inhibitory Peptide Prevents Loss of Dopaminergic Neurons and Alleviates Behavioral Changes in an MPTP Induced Parkinson’s Disease Mouse Model
por: He, Rongni, et al.
Publicado: (2018)

Peripheral Inflammation Enhances Microglia Response and Nigral Dopaminergic Cell Death in an in vivo MPTP Model of Parkinson’s Disease
por: García-Domínguez, Irene, et al.
Publicado: (2018)

Lobeline shows protective effects against MPTP-induced dopaminergic neuron death and attenuates behavior deficits in animals
por: LI, CHAO-YUE, et al.
Publicado: (2014)

Vitexin protects dopaminergic neurons in MPTP-induced Parkinson’s disease through PI3K/Akt signaling pathway
por: Hu, Ming, et al.
Publicado: (2018)

Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP
por: Viveros-Paredes, Juan M., et al.
Publicado: (2017)

TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone
por: Zheng, Cong, et al.
Publicado: (2018)

Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson's disease
por: Chung, Young C, et al.
Publicado: (2017)

Depletion of microglia augments the dopaminergic neurotoxicity of MPTP
por: Yang, Xiaoxia, et al.
Publicado: (2018)

Interleukin-4 Protects Dopaminergic Neurons In vitro but Is Dispensable for MPTP-Induced Neurodegeneration In vivo
por: Hühner, Laura, et al.
Publicado: (2017)

Ukgansan Protects Dopaminergic Neurons against MPTP-Induced Neurotoxicity via the Nurr1 Signaling Pathway
por: Chae, In-Cheol, et al.
Publicado: (2022)

Norfluoxetine Prevents Degeneration of Dopamine Neurons by Inhibiting Microglia-Derived Oxidative Stress in an MPTP Mouse Model of Parkinson's Disease
por: Kim, Kyung In, et al.
Publicado: (2018)

Batryticatus Bombyx Protects Dopaminergic Neurons against MPTP-Induced Neurotoxicity by Inhibiting Oxidative Damage
por: Lim, Hye-Sun, et al.
Publicado: (2019)

Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice
por: Oliveira, Sara R., et al.
Publicado: (2021)

β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins
por: Ninkina, Natalia, et al.
Publicado: (2021)

Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson’s disease
por: St-Amour, Isabelle, et al.
Publicado: (2012)

Depletion of canonical Wnt signaling components has a neuroprotective effect on midbrain dopaminergic neurons in an MPTP-induced mouse model of Parkinson’s disease
por: DAI, TING-LI, et al.
Publicado: (2014)

Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson’s disease
por: Qiao, Chen, et al.
Publicado: (2018)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Particulate Matter Exacerbates the Death of Dopaminergic Neurons in Parkinson’s Disease through an Inflammatory Response
por: Choi, Dabin, et al.
Publicado: (2022)

Inhibitory effect of thiacremonone on MPTP-induced dopaminergic neurodegeneration through inhibition of p38 activation
por: Hwang, Chul Ju, et al.
Publicado: (2016)

Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons
por: Aguirre, Pabla, et al.
Publicado: (2015)

PET Analysis of Dopaminergic Neurodegeneration in Relation to Immobility in the MPTP-Treated Common Marmoset, a Model for Parkinson’s Disease
por: Ando, Kiyoshi, et al.
Publicado: (2012)

Brain-specific NRSF deficiency aggravates dopaminergic neurodegeneration and impairs neurogenesis in the MPTP mouse model of Parkinson’s disease
por: Huang, Dongping, et al.
Publicado: (2019)

Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson’s disease
por: Peng, Qinyu, et al.
Publicado: (2022)

Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson’s Disease
por: Marchetti, Bianca
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gd1sddcp45f744c3crf9ci3a0t